These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29549269)

  • 1. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study.
    Jang HR; Kang D; Sinn DH; Gu S; Cho SJ; Lee JE; Huh W; Paik SW; Ryu S; Chang Y; Shafi T; Lazo M; Guallar E; Cho J; Gwak GY
    Sci Rep; 2018 Mar; 8(1):4718. PubMed ID: 29549269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up.
    Zeng J; Sun C; Sun WL; Chen GY; Pan Q; Yan SY; Xu ZJ; Chen YW; Fan JG
    J Dig Dis; 2017 Apr; 18(4):229-236. PubMed ID: 28296249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
    Seko Y; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Mizuno N; Takemura M; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Okanoue T; Itoh Y
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower eGFR is associated with increased probability of liver fibrosis in Chinese diabetic patients.
    Wang Y; Yu Y; Wan H; Chen Y; Xia F; Zhang W; Zhang K; Gu X; Zhang Y; Lin Z; Yu Y; Wang N; Lu Y
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3294. PubMed ID: 32017389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.
    Targher G; Mantovani A; Pichiri I; Mingolla L; Cavalieri V; Mantovani W; Pancheri S; Trombetta M; Zoppini G; Chonchol M; Byrne CD; Bonora E
    Diabetes Care; 2014 Jun; 37(6):1729-36. PubMed ID: 24696459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study.
    Derebail VK; Ciccone EJ; Zhou Q; Kilgore RR; Cai J; Ataga KI
    Am J Kidney Dis; 2019 Jul; 74(1):47-55. PubMed ID: 30797615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study.
    Hara M; Tanaka S; Torisu K; Matsukuma Y; Tsuchimoto A; Tokumoto M; Ooboshi H; Nakano T; Tsuruya K; Kitazono T
    Clin Exp Nephrol; 2021 Aug; 25(8):822-834. PubMed ID: 33856608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
    Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.
    Önnerhag K; Dreja K; Nilsson PM; Lindgren S
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):542-550. PubMed ID: 30827925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H; Dawwas GK; Liu X; Nguyen MH
    J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.
    Arase Y; Suzuki F; Kobayashi M; Suzuki Y; Kawamura Y; Matsumoto N; Akuta N; Kobayashi M; Sezaki H; Saito S; Hosaka T; Ikeda K; Kumada H; Ohmoto Y; Amakawa K; Tsuji H; Hsieh SD; Kato K; Tanabe M; Ogawa K; Hara S; Kobayashi T
    Intern Med; 2011; 50(10):1081-7. PubMed ID: 21576832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus.
    Aubert L; Sandino J; Gutiérrez-Solís E; García-Martín F; Segura J; Porrini E; Morales E
    Nephrol Dial Transplant; 2022 May; 37(6):1125-1131. PubMed ID: 33983444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
    Bellinato F; Goio I; Malara G; Rosato A; Targher G; Girolomoni G; Gisondi P
    J Cutan Med Surg; 2022; 26(3):249-255. PubMed ID: 34894782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
    Seo DH; Suh YJ; Cho Y; Ahn SH; Seo S; Hong S; Lee YH; Choi YJ; Lee E; Kim SH
    Diabetes Metab J; 2022 Jul; 46(4):630-639. PubMed ID: 35081304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.